Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific ...
Opinion
Zacks Investment Research on MSNOpinion
Top Research Reports for Microsoft, Amazon.com & Eli Lilly
Tuesday, November 18, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft ...
Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Eduardo ...
The new generation of obesity medications are inducing greater weight loss than any prior pharmacotherapy. There is discussion now about how to support fat loss while protecting lean mass.“Lean mass ...
Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...
Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...
LillyDirect’s Jennifer Mazur on the platform’s new partnership with Walmart, future of DTC platforms
Mazur, GM of LillyDirect, breaks down the platform’s new partnership with Walmart and its implications for the pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results